General
publicado em 09/02/2013 às 07h00:00
   Dê o seu voto:

Food and Drug Administration approves first generic version of cancer drug

Generic Injection administered intravenously aims to reduce shortages of the drug Doxil around the country

 
font size
A-
A+

The U.S. Food and Drug Administration today approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection).

Doxorubicin hydrochloride liposome injection is currently on the FDA' s drug shortage list. For products on the shortage list, the FDA' s Office of Generic Drugs is using a priority review system to expedite the review of generic applications to help alleviate shortages.

" The agency is committed to doing everything we can to address drug shortages so that patients can get the medicines they need when they need them," said Capt. Valerie Jensen, R.Ph., director, Drug Shortage Staff, Center for Drug Evaluation and Research, FDA. " For the past year, the FDA has been working to ensure that supplies of doxorubicin HCl liposome injection were not interrupted."

Generic drugs approved by the FDA have the same high quality and strength as brand-name drugs. The generic manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

The generic is made by Sun Pharma Global FZE (Sun). Doxorubicin hydrochloride liposome injection is administered intravenously by a health care professional. Sun' s generic will be available in 20 milligram and 50 milligram vials.

In February 2012, to address the shortage of doxorubicin hydrochloride liposome injection, the FDA announced it would exercise enforcement discretion for temporary controlled importation of Lipodox (doxorubicin hydrochloride liposome injection), an alternative to Doxil produced by Sun and its authorized distributor, Caraco Pharmaceutical Laboratories Ltd. that is not approved in the United States. Enforcement discretion was also used to release one lot of Janssen' s Doxil made under an unapproved manufacturing process.

For the present time, FDA intends to continue exercising enforcement discretion for importation of Lipodox, and limited supplies of Doxil are available. Once supplies of Sun' s generic doxorubicin hydrochloride liposome injection are sufficient to meet projected demand, FDA expects to stop exercising enforcement discretion for any unapproved doxorubicin HCl liposomal product.

Source: Isaude.net
   Palavras-chave:   Generic drug    Doxil    Generic version    Anticancer    FDA    Valerie Jensen   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Food and Drug Administration approves first generic version of cancer drug
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Food and Drug Administration approves first generic version of cancer drug


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
generic drug    Doxil    generic version    anticancer    FDA    Valerie Jensen   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.